• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高度角膜散光眼的三焦点散光型人工晶状体的视力和屈光效果。

Visual and Refractive Outcomes of a Trifocal Toric Intraocular Lens Implanted in Eyes With High Corneal Astigmatism.

出版信息

J Refract Surg. 2023 Apr;39(4):229-234. doi: 10.3928/1081597X-20230127-01. Epub 2023 Apr 1.

DOI:10.3928/1081597X-20230127-01
PMID:37040209
Abstract

PURPOSE

To analyze the refractive and visual outcomes following cataract surgery and implantation of a trifocal toric intraocular lens (IOL) in eyes with high degrees of corneal astigmatism.

METHODS

A total of 29 eyes from 21 patients who underwent implantation of a trifocal toric IOL (FineVision PODFT; PhysIOL) were evaluated in this study. Phacoemulsification with femto-second laser and intraoperative aberrometry were performed in all cases. All IOLs used exhibited a cylinder power of 3.75 diopters (D) or greater. The main outcome measures were refractive error and corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA) values. Eyes were evaluated during a follow-up period of 5 years.

RESULTS

A total of 96.30%, 100%, 95.83%, and 89.47% of eyes were within ±1.00 D at 1, 2, 3, and 5 years postoperatively, respectively. Furthermore, 92.31%, 86.36%, 82.61%, and 84.21% of eyes showed a refractive cylinder value of ±1.00 D at 1, 2, 3, and 5 years postoperatively, respectively. During the entire follow-up period, between 81.48% and 91.30% of eyes showed a CDVA of 20/25 or better. The mean monocular Snellen decimal CDVA values were 0.90 ± 0.12, 0.90 ± 0.11, 0.91 ± 0.11, and 0.90 ± 0.12 at 1, 2, 3, and 5 years postoperatively, respectively. No significant rotation was reported in any eye during follow-up.

CONCLUSIONS

The current study suggests that use of this trifocal toric IOL in eyes with high amounts of corneal astigmatism provides accurate refractive outcomes with good distance visual acuity. .

摘要

目的

分析高度角膜散光患者白内障手术后植入三焦点散光人工晶状体(IOL)的屈光和视觉结果。

方法

本研究共评估了 21 名患者的 29 只眼,这些患者均接受了三焦点散光 IOL(FineVision PODFT;PhysIOL)植入术。所有病例均行飞秒激光白内障超声乳化术及术中像差测量。所有使用的 IOL 柱镜度数均为 3.75 屈光度(D)或以上。主要观察指标为屈光误差和矫正远视力(CDVA)及未矫正远视力(UDVA)值。在 5 年的随访期间对眼睛进行评估。

结果

术后 1、2、3、5 年,分别有 96.30%、100%、95.83%和 89.47%的眼在±1.00 D 以内;此外,术后 1、2、3、5 年,分别有 92.31%、86.36%、82.61%和 84.21%的眼屈光度柱值在±1.00 D 以内。在整个随访期间,81.48%至 91.30%的眼显示 CDVA 达到 20/25 或更好。单眼 Snellen 十进制 CDVA 平均值分别为术后 1、2、3、5 年的 0.90±0.12、0.90±0.11、0.91±0.11 和 0.90±0.12。随访期间无眼发生显著旋转。

结论

本研究表明,在高度角膜散光眼中使用这种三焦点散光 IOL 可提供准确的屈光结果和良好的远视力。

相似文献

1
Visual and Refractive Outcomes of a Trifocal Toric Intraocular Lens Implanted in Eyes With High Corneal Astigmatism.高度角膜散光眼的三焦点散光型人工晶状体的视力和屈光效果。
J Refract Surg. 2023 Apr;39(4):229-234. doi: 10.3928/1081597X-20230127-01. Epub 2023 Apr 1.
2
Trifocal toric intraocular lenses in eyes with low amount of corneal astigmatism.用于角膜散光量低的眼睛的三焦点环曲面人工晶状体。
Int J Ophthalmol. 2020 Oct 18;13(10):1567-1573. doi: 10.18240/ijo.2020.10.09. eCollection 2020.
3
Transitional conic toric intraocular lens evaluation after femtosecond laser-assisted cataract surgery using intraoperative aberrometry.飞秒激光辅助白内障手术后使用术中像差仪评估过渡锥形双折射人工晶状体。
Int Ophthalmol. 2022 Jan;42(1):177-189. doi: 10.1007/s10792-021-02012-8. Epub 2021 Aug 23.
4
Cataract surgery with toric intraocular lens implantation in patients with high corneal astigmatism.高度角膜散光患者的散光型人工晶状体白内障手术。
J Cataract Refract Surg. 2011 Aug;37(8):1403-10. doi: 10.1016/j.jcrs.2011.03.034.
5
Rotational Stability of Monofocal and Trifocal Intraocular Toric Lenses With Identical Design and Material but Different Surface Treatment.具有相同设计和材料但表面处理不同的单焦点和三焦点有晶状体眼人工晶状体的旋转稳定性
J Refract Surg. 2018 Feb 1;34(2):84-91. doi: 10.3928/1081597X-20171211-01.
6
Clinical Outcomes After Cataract Surgery With a New Transitional Toric Intraocular Lens.使用新型过渡性散光人工晶状体进行白内障手术后的临床结果
J Refract Surg. 2016 Jul 1;32(7):452-9. doi: 10.3928/1081597X-20160428-07.
7
Comparison of 3-month visual outcomes of a spherical and a toric trifocal intraocular lens.球性和散光性三焦点人工晶状体 3 个月的视觉效果比较。
J Cataract Refract Surg. 2019 Feb;45(2):135-145. doi: 10.1016/j.jcrs.2018.09.025. Epub 2018 Nov 30.
8
Outcomes After Implantation of a Trifocal Toric Intraocular Lens Using Intraoperative Aberrometry, Digital Image Tracking, and Femtosecond Laser.使用术中像差仪、数字图像跟踪和飞秒激光植入三焦点散光人工晶状体后的效果
Clin Ophthalmol. 2024 Jul 11;18:2033-2039. doi: 10.2147/OPTH.S460060. eCollection 2024.
9
Comparison of the visual outcomes and OPD-scan results of AMO Tecnis toric and Alcon Acrysof IQ toric intraocular lenses.AMO Tecnis toric 与 Alcon Acrysof IQ toric 人工晶状体的视觉效果和 OPD 扫描结果比较。
J Refract Surg. 2012 Aug;28(8):551-5. doi: 10.3928/1081597X-20120703-03. Epub 2012 Jul 13.
10
Toric intraocular lens versus monofocal intraocular lens implantation and photorefractive keratectomy: a randomized controlled trial.散光人工晶状体与单焦点人工晶状体植入及准分子激光原位角膜磨镶术:一项随机对照试验。
Am J Ophthalmol. 2015 Sep;160(3):479-486.e2. doi: 10.1016/j.ajo.2015.06.007. Epub 2015 Jun 19.

引用本文的文献

1
Clinical outcomes of a hydrophobic trifocal diffractive intraocular lens: a literature review.疏水三焦点衍射人工晶状体的临床结果:文献综述
Front Med (Lausanne). 2025 Jan 22;12:1533161. doi: 10.3389/fmed.2025.1533161. eCollection 2025.
2
Accuracy of intraoperative aberrometry versus preoperative biometry for intraocular lens power selection in short and long eyes.短眼和长眼中用于人工晶状体屈光度选择的术中像差仪测量与术前生物测量的准确性比较
Front Med (Lausanne). 2024 Oct 15;11:1466885. doi: 10.3389/fmed.2024.1466885. eCollection 2024.
3
Hydrophobic Trifocal Toric Intraocular Lens Outcomes in Japanese Eyes After Cataract Surgery.
日本白内障手术后眼内植入疏水三焦点散光人工晶状体的效果
Clin Ophthalmol. 2024 Jul 11;18:2021-2031. doi: 10.2147/OPTH.S471846. eCollection 2024.
4
Visual and Refractive Outcomes of a New Hydrophobic Trifocal Toric Intraocular Lens.新型疏水三焦点环曲面人工晶状体的视觉和屈光效果
Clin Ophthalmol. 2024 Apr 3;18:997-1007. doi: 10.2147/OPTH.S453565. eCollection 2024.